The fate and lifespan of human monocyte subsets in steady state and systemic inflammation.

Patel AA, Zhang Y, Fullerton JN, Boelen L, Rongvaux A, Maini AA, Bigley V, Flavell RA, Gilroy DW, Asquith B, Macallan D, Yona S. · 2017

Read The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. by Patel AA, Zhang Y, Fullerton JN, Boelen L, Rongvaux A, Maini AA, Bigley V, Flavell RA, Gilroy DW, Asquith B, Macallan D, Yona S. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5502436.txt.

Introduction

Patel and co-authors report an immunology study in the Journal of Experimental Medicine. It tracks the three kinds of monocytes that patrol human blood. Classical monocytes make up about 85 percent of the pool. How the subsets relate, and how long each survives, was unknown. The team used safe heavy-water labeling to follow the cells in people.

Classical monocytes proved short-lived precursors, they report. They can mature into intermediate and then nonclassical monocytes. All three subsets circulate in a steady balance at rest. Widespread inflammation triggers an emergency release of classical monocytes, though. The work gives human monocyte lifespans their first firm numbers.

Catalog record

CREATORPatel AA, Zhang Y, Fullerton JN, Boelen L, Rongvaux A, Maini AA, Bigley V, Flavell RA, Gilroy DW, Asquith B, Macallan D, Yona S.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5502436

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The fate and lifespan of human monocyte subsets in steady state and systemic inflammation By Amit A. Patel, Yan Zhang, James N. Fullerton, Lies Boelen, Anthony Rongvaux, Alexander A. Maini, Venetia Bigley, Richard A. Flavell, Derek W. Gilroy, Becca Asquith, Derek Macallan, Simon Yona Published in: The Journal of Experimental Medicine DOI: 10.1084/jem.20170355 ABSTRACT Using stable isotope labeling, Patel et al. establish the lifespan of all three human monocyte subsets that circulate in dynamic equilibrium; in steady state, classical monocytes are short-lived precursors with the potential to become intermediate and nonclassical monocytes. They highlight that systemic inflammation induces an emergency release of classical monocytes into the circulation. INTRODUCTION The mononuclear phagocyte system comprises three types of cells: monocytes, macrophages, and DCs, as well as their committed bone marrow progenitors (van Furth et al., 1972; Yona and Gordon, 2015). Collectively, the cells of the mononuclear phagocyte system play key functions in maintaining tissue homeostasis during steady state as well as orchestrating the genesis and resolution of the immune response (Davies et al., 2013; Wynn et al., 2013; Ginhoux and Jung, 2014). It is now recognized that the majority of tissue macrophage populations are seeded before birth (Ginhoux et al., 2010; Schulz et al., 2012; Guilliams et al., 2013; Hashimoto et al., 2013; Yona et al., 2013; Mass et al., 2016) and maintained via self-proliferation throughout adulthood with minimal monocyte input (Soucie et al., 2016). Conversely, DCs and monocytes arise from distinct adult hematopoietic stem cell precursors in the bone marrow (Fogg et al., 2006; Naik et al., 2007; Onai et al., 2007, 2013; Liu et al., 2009; Hettinger et al., 2013; Breton et al., 2015; Lee et al., 2015). Circulating monocytes represent a versatile and dynamic cell population, composed of multiple subsets which differ in phenotype, size, morphology, and transcriptional profiles and are defined by their location in the blood (Geissmann et al., 2003; Cros et al., 2010; Ingersoll et al., 2010; Wong et al., 2011; Mildner et al., 2013a). These discrete monocyte subsets can be distinguished by the expression of CD14 and CD16 in humans and Ly6C, CCR2, and CX3CR1 in mice (Ziegler-Heitbrock et al., 2010). In humans, CD14+ CD16− (classical) monocytes make up ∼85% of the circulating monocyte pool, whereas the remaining ∼15% consist of CD14+ CD16+ (intermediate) and CD14lo CD16+ (nonclassical) monocytes (Passlick et al., 1989; Wong et al., 2011). Similarly, in mice, two populations of monocytes have been described: Ly6Chi CCR2+ CX3CR1int and Ly6Clo CCR2− CX3CR1hi, representing classical and nonclassical monocytes, respectively (Geissmann et al., 2003). Monocyte egression from the bone marrow requires expression of the chemokine receptor CCR2, which is restricted to classical monocytes (Shi and Pamer, 2011). Classical monocytes are rapidly recruited to sites of infection (Serbina and Pamer, 2006; Liao et al., 2017) and injury (Nahrendorf et al., 2007; Zigmond et al., 2014), where they exhibit considerable functional plasticity (Arnold et al., 2007; Avraham-Davidi et al., 2013). Interestingly, classical monocytes replenish resident peripheral monocyte–derived cells under steady-state conditions (Varol et al., 2009; Tamoutounour et al., 2013; Bain et al., 2014; Guilliams et al., 2014). Nonclassical monocytes have been proposed to act as custodians of vasculature by patrolling endothelial cell integrity in an LFA-1–dependent fashion (Auffray et al., 2007). During steady state, rodent blood monocyte subsets represent stages of a developmental sequence; classical monocytes have been shown to convert into nonclassical monocytes over time (Sunderkötter et al., 2004; Yrlid et al., 2006; Varol et al., 2007; Yona et al., 2013; Thomas et al., 2016). However, it remains to be shown what, if any, relationships exist among the three principal human monocyte subsets and how long each of these subsets resides in the circulation. Although the vast majority of information concerning mononuclear phagocyte ontogeny, function, and kinetics is derived from mouse studies, due to the challenging nature of performing studies in a clinical setting, some important insights into human monocyte biology have been gained from studying pathological states. Patients with a GATA2 mutation (encoding the GATA-binding protein 2) have an absence of all blood monocytes; despite this, their resident dermal and lung macrophages remain unaffected, suggesting that the development of these populations is independent of blood monocytes (Bigley et al., 2011). Interestingly, patients with rheumatoid arthritis exhibit an increase in circulating intermediate monocytes (Cooper et al., 2012). Furthermore, stroke patients have been reported to increase their intermediate monocytes 2 d after their initial insult, and this increase inversely correlated with mortality (Urra et al., 2009). These data raise the questions of whether and how circulating human monocyte subsets are related, how long each population circulates, and what impact inflammation has on this process. Fifty years ago, van Furth and Cohn performed a series of elegant studies examining monocyte dynamics in rodents with 3H-thymidine. They concluded that monocytes transit from the bone marrow to the blood, with a circulating half-life of ∼22 h (van Furth and Cohn, 1968). More recently, studies in mice demonstrated that classical monocytes have a half-life of <1 d before converting into nonclassical monocytes with a half-life of ∼2.2 d (Yona et al., 2013). Nevertheless, the fate and kinetics of human monocyte subsets under steady state and inflammation remain to be resolved. A major breakthrough in examining in vivo human leukocyte kinetics came with the advent of nontoxic stable isotope labeling approaches (Macallan et al., 1998; Busch et al., 2007). Specifically, the deuterium from deuterium-labeled glucose or heavy water incorporates stably into the backbone of DNA of dividing cells. The deuterium-glucose labeling approach is particularly suited to the study of rapidly dividing cells and has been applied in humans to study the turnover of T cell populations such as regulatory T cells (Vukmanovic-Stejic et al., 2006), to memory T cell subsets in HIV infection (Zhang et al., 2013), and, more recently, to cells of the innate immune system, such as neutrophils (Lahoz-Beneytez et al., 2016). Here, we report a series of studies investigating the development and kinetics of human monocyte subpopulations. We hypothesized that the fate and kinetics of the three monocyte subsets (classical, intermediate, and nonclassical) were intimately linked and could be defined in kinetic terms. We first investigated the steady-state kinetics in healthy human volunteers using in vivo deuterium-labeled glucose as a precursor. We then repeated these studies in the context of endotoxin-induced systemic inflammation, where we observed a transient depletion of almost the entire circulating monocyte pool; in this way, we were able to study the early repopulation of an “empty” blood compartment. Finally, we tested our sequential development hypothesis in the humanized MISTRG mouse (Rongvaux et al., 2014) to build a comprehensive picture of how human monocyte subsets are regulated in steady state and systemic inflammation. RESULTS AND DISCUSSION Characterization of human monocyte subset kinetics under steady state The literature has not always clearly distinguished between monocyte subsets, making interpretation confusing. We chose to follow a systematic strategy to identify the three conventional monocyte subsets of interest. Lin− (CD3, CD19, CD20, CD56, and CD66b) HLA-DR+ cells were separated into (1) CD14+CD16− classical monocytes, (2) CD14+CD16+ intermediate monocytes, and (3) CD14loCD16+ nonclassical monocytes (Fig. 1 a; Ziegler-Heitbrock et al., 2010). In addition to CD14 and CD16 expression, we confirmed additional membrane marker expression between monocyte subsets (Fig. 1 b and

Read the complete text